NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-337-2001-0-US-02 Immunoconjugates Comprising CD4 and Immunoglobulin Molecules for the Treatment of HIV Infection US National Stage 10/493,676 7368114 Abandoned PDF
NCI E-281-2002-0-US-02 Hypoxia-Inducible Factor 1alpha Variants and Methods of Use US ORD 10/831,380 7193053 Abandoned PDF
NCI E-336-2001-0-US-02 Amyloid B is a Ligand For FPR Class Receptors US National Stage 10/831,524 Abandoned
NHLBI E-014-2004-0-US-01 Monoclonal Antibody MP804 And Its Detection Of Primitive Stem Cells In Adult Skeletal Muscle That Mature In Vitro Into Neuronal Cells US 60/565,101 Abandoned
NCI E-045-2004-0-US-01 Methods and Compositions for Diagnosing AIDS and Other Diseases and Conditions Involving Immune System Activation US 60/564,588 Abandoned
NCI E-093-1996-3-DE-22 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES DE EP 04009529.1 Expired
NCI E-093-1996-3-FR-21 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES FR EP 04009529.1 Expired
NCI E-093-1996-3-GB-23 O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES GB EP 04009529.1 Expired
NIDDK E-291-1998-0-US-02 Immune Activation by Double-Stranded Polynucleotides US CON 10/830,898 Abandoned
NHGRI E-027-2004-0-US-01 Rapid Integration Site Maping US 60/564,095 Abandoned
NHGRI E-027-2004-0-CA-02 Rapid Integration Site Maping CA ORD 2465396 Abandoned
NCI E-035-2004-1-US-01 Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration To Sites Of Brain And Spinal Cord Injury US 60/563,397 Abandoned
NIAID E-004-2004-2-AU-07 Anti-Plasmodium Antibodies and Methods Of Use AU DIV 2004201615 Expired
NCI E-091-2007-0-US-28 DNA Fragments from MAL Variant Of LAV (HIV-1) Virus US DIV 09/834,627 6635752 Expired PDF
NICHD E-061-2005-0-US-01 A Novel Marker For Carkiomyocyte Progenitor Cells US 60/562,931 Abandoned
NIAID E-178-2008-0-US-01 Methods to detect CD-4-induced antibodies US 60/562,824 Abandoned
NIAMS E-353-2001-2-US-02 Methods Of Using Deacetylase Inhibitors As Tools To Promote Cell Differentiation And Regeneration US National Stage 10/492,901 7229963 Expired PDF
NCI E-130-2001-0-US-05 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By ENV-CD4-CO-Receptor Complexes US National Stage 10/492,729 7223844 Abandoned PDF
NIDCR E-173-1998-0-AU-07 COMPLEX FORMED BY N-LINKED GLYCOPROTEINS (SIBLINGS) AND FACTOR H AU DIV 2004201550 Abandoned
NHLBI E-361-2001-0-US-10 A Method and Apparatus to improve an MRI Image US National Stage 10/492,897 7154268 Abandoned PDF
NCI E-143-1996-0-US-16 NOVEL LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY US CON 10/825,803 7001614 Expired PDF
NCI E-105-2004-0-US-01 Minimally Immunogenic Germline Sequence Variants of Humanized COL-1 Antibody and Their Use US 60/562,781 Abandoned
NCI E-127-2003-0-US-02 Profiling Of Transcriptional Targets: An Integrated Approach To Define And Evaluate Molecular Targets Of Signal Transduction Pathways US ORD 10/822,140 Abandoned
NCI E-292-2001-1-US-02 Use Of Mx GTPase In The Prognosis And Treatment Of Cancer US National Stage 10/492,396 Abandoned
NIAID E-173-2004-0-US-01 Method of Using Adenoviral Vectors to Induce an Immune Response US 60/561,341 Abandoned
NIDDK E-098-2003-1-PCT-01 Inducing a T Cell Response With Recombinant Pestivirus Replicons or Recombinant Pestivirus Replicon-Transfected Dendritic Cells PCT PCT COMB PCT/US2004/11018 Expired
NIA E-158-2003-1-US-02 Computer -Based Model For The Identification And Characterization Of Non-Competitive Inhibitors (Nci) Of The Nicotinic Acetylcholine Receptor US National Stage 10/820,809 7749984 Abandoned PDF
NHLBI E-046-2003-0-PCT-02 Spiral Column For Dual Countercurrent Chromatography PCT PCT PCT/US2004/11063 Abandoned
NIA E-158-2003-1-PCT-01 Computer-Based Model For Identification and Characterization of Non-Competitive Inhibitors of Nicotinic Acetylcholine Receptors and Related Ligand-Gated Ion Channel Receptors PCT PCT COMB PCT/US2004/10978 Abandoned
NIA E-158-2003-1-EP-04 Dextromethorphan Derivatives for Use in Inhibiting Ligand-Gated Ion Channel Receptors EP National Stage 04759333.0 Abandoned
NCI E-124-2004-0-US-01 Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions US 60/560,900 Abandoned
NIA E-158-2003-1-CA-03 Computer-Based Model For Identification and Characterization of Non-Competitive Inhibitors of Nicotinic Acetylcholine Receptors and Related Ligand-Gated Ion Channel Receptors CA National Stage 2521808 Abandoned
NCI E-075-2001-0-US-02 Methods and Compositions for Production and Purification of Recombinant Staphylococcal Enterotoxin B(rSEB) US National Stage 10/492,105 Abandoned
NIMH E-169-2004-0-US-01 Reporter Plasmid Phage Packaging System For Detection Of Bacteria US 60/560,392 Abandoned
NICHD E-293-1998-0-US-04 Cloning and Characterization of Two Novel M-RNA Transcription Factors US DIV 10/819,860 Abandoned
NCI E-138-2004-0-US-01 A Method To Develop B Cell Epitope-based Effective Vaccine Modaliites For Smallpox For Both Immune-competent And Immune-compromised Individuals US 60/559,906 Abandoned
NINDS E-005-2004-0-PCT-01 Methods for the Selection of Subjects for Multiple Sclerosis Therapy PCT PCT PCT/US2004/10584 Expired
NCI E-148-2003-0-PCT-02 Gene Expressed in Prostate Cancer, Methods and Use Thereof PCT PCT PCT/US2004/10588 Expired
NIAID E-165-2004-0-US-01 SARS Coronavirus MVA Vaccines And Therapy US 60/558,995 Abandoned
NICHD E-107-2003-0-AU-06 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. AU National Stage 2004228631 Abandoned
NICHD E-107-2003-0-BE-12 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. BE EP 04758715.9 Abandoned
NICHD E-107-2003-0-LI-20 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi.
1613641 		LI EP 04758715.9 Abandoned
NICHD E-107-2003-0-NL-21 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. NL EP 04758715.9 Abandoned
NICHD E-107-2003-0-ES-15 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. ES EP 04758715.9 Abandoned
NICHD E-107-2003-0-GB-17 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. GB EP 04758715.9 Abandoned
NICHD E-107-2003-0-CH-13 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. CH EP 04758715.9 Abandoned
NICHD E-107-2003-0-DE-14 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. DE EP 04758715.9 Abandoned
NICHD E-107-2003-0-FR-16 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. FR EP 04758715.9 Abandoned
NICHD E-107-2003-0-IE-18 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. IE EP 04758715.9 Abandoned
NICHD E-107-2003-0-IT-19 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. IT EP 04758715.9 Abandoned